Boston Scientific Corporation (BSX)
USD 94.27
(0.64%)
USD 94.27
(0.64%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.96 Billion USD | -3.25% |
| 2022 | 9.26 Billion USD | 0.78% |
| 2021 | 9.19 Billion USD | -3.53% |
| 2020 | 9.52 Billion USD | 7.5% |
| 2019 | 8.86 Billion USD | 85.49% |
| 2018 | 4.77 Billion USD | 26.48% |
| 2017 | 3.77 Billion USD | -30.31% |
| 2016 | 5.42 Billion USD | -4.48% |
| 2015 | 5.67 Billion USD | 47.03% |
| 2014 | 3.85 Billion USD | -8.92% |
| 2013 | 4.23 Billion USD | -0.35% |
| 2012 | 4.25 Billion USD | -0.12% |
| 2011 | 4.25 Billion USD | -13.72% |
| 2010 | 4.93 Billion USD | -16.58% |
| 2009 | 5.91 Billion USD | -12.28% |
| 2008 | 6.74 Billion USD | -15.0% |
| 2007 | 7.93 Billion USD | -10.82% |
| 2006 | 8.89 Billion USD | 377.2% |
| 2005 | 1.86 Billion USD | 63.65% |
| 2004 | 1.13 Billion USD | -2.82% |
| 2003 | 1.17 Billion USD | 38.37% |
| 2002 | 847 Million USD | -12.95% |
| 2001 | 973 Million USD | 69.51% |
| 2000 | 574 Million USD | -15.34% |
| 1999 | 678 Million USD | -50.29% |
| 1998 | 1.36 Billion USD | 2845.57% |
| 1997 | 46.3 Million USD | -1.91% |
| 1996 | 47.2 Million USD | 263.08% |
| 1995 | 13 Million USD | 46.07% |
| 1994 | 8.9 Million USD | 48.33% |
| 1993 | 6 Million USD | -1.64% |
| 1992 | 6.1 Million USD | -71.5% |
| 1991 | 21.4 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 9.23 Billion USD | 2.69% |
| 2024 Q1 | 9.91 Billion USD | 11.25% |
| 2024 Q2 | 8.98 Billion USD | -5.7% |
| 2023 Q2 | 8.89 Billion USD | 0.45% |
| 2023 FY | 8.96 Billion USD | -3.25% |
| 2023 Q1 | 8.85 Billion USD | -4.39% |
| 2023 Q4 | 8.96 Billion USD | 1.99% |
| 2023 Q3 | 8.78 Billion USD | -1.23% |
| 2022 Q1 | 9.44 Billion USD | 2.77% |
| 2022 Q2 | 9.15 Billion USD | -3.05% |
| 2022 Q4 | 9.26 Billion USD | 3.9% |
| 2022 FY | 9.26 Billion USD | 0.78% |
| 2022 Q3 | 8.91 Billion USD | -2.65% |
| 2021 Q3 | 9.19 Billion USD | -0.04% |
| 2021 Q1 | 9.43 Billion USD | -1.01% |
| 2021 FY | 9.19 Billion USD | -3.53% |
| 2021 Q2 | 9.2 Billion USD | -2.42% |
| 2021 Q4 | 9.19 Billion USD | -0.09% |
| 2020 Q1 | 9.59 Billion USD | 8.26% |
| 2020 Q3 | 9.32 Billion USD | -2.25% |
| 2020 Q4 | 9.52 Billion USD | 2.21% |
| 2020 FY | 9.52 Billion USD | 7.5% |
| 2020 Q2 | 9.53 Billion USD | -0.6% |
| 2019 Q4 | 8.86 Billion USD | -7.47% |
| 2019 Q1 | 7.57 Billion USD | 58.55% |
| 2019 Q2 | 7.57 Billion USD | 0.03% |
| 2019 Q3 | 9.57 Billion USD | 26.4% |
| 2019 FY | 8.86 Billion USD | 85.49% |
| 2018 Q3 | 4.77 Billion USD | 0.04% |
| 2018 Q1 | 4.76 Billion USD | 26.24% |
| 2018 FY | 4.77 Billion USD | 26.48% |
| 2018 Q2 | 4.77 Billion USD | 0.17% |
| 2018 Q4 | 4.77 Billion USD | -0.02% |
| 2017 Q3 | 4.41 Billion USD | -8.32% |
| 2017 FY | 3.77 Billion USD | -30.31% |
| 2017 Q1 | 5.5 Billion USD | 1.64% |
| 2017 Q2 | 4.81 Billion USD | -12.56% |
| 2017 Q4 | 3.77 Billion USD | -14.47% |
| 2016 Q1 | 5.42 Billion USD | -4.41% |
| 2016 Q3 | 5.17 Billion USD | -0.04% |
| 2016 Q2 | 5.17 Billion USD | -4.63% |
| 2016 Q4 | 5.42 Billion USD | 4.82% |
| 2016 FY | 5.42 Billion USD | -4.48% |
| 2015 Q3 | 5.79 Billion USD | 14.34% |
| 2015 Q1 | 3.84 Billion USD | -0.36% |
| 2015 FY | 5.67 Billion USD | 47.03% |
| 2015 Q4 | 5.67 Billion USD | -2.1% |
| 2015 Q2 | 5.06 Billion USD | 31.83% |
| 2014 Q1 | 4.24 Billion USD | 0.19% |
| 2014 FY | 3.85 Billion USD | -8.92% |
| 2014 Q3 | 4.24 Billion USD | -0.07% |
| 2014 Q2 | 4.25 Billion USD | 0.16% |
| 2014 Q4 | 3.85 Billion USD | -9.18% |
| 2013 Q2 | 3.64 Billion USD | -14.19% |
| 2013 Q1 | 4.25 Billion USD | -0.05% |
| 2013 FY | 4.23 Billion USD | -0.35% |
| 2013 Q4 | 4.23 Billion USD | -0.21% |
| 2013 Q3 | 4.24 Billion USD | 16.42% |
| 2012 Q1 | 4.25 Billion USD | -0.05% |
| 2012 Q2 | 4.25 Billion USD | -0.05% |
| 2012 Q3 | 4.25 Billion USD | -0.02% |
| 2012 Q4 | 4.25 Billion USD | 0.0% |
| 2012 FY | 4.25 Billion USD | -0.12% |
| 2011 Q2 | 4.19 Billion USD | -10.13% |
| 2011 Q1 | 4.67 Billion USD | -5.35% |
| 2011 Q3 | 4.25 Billion USD | 1.48% |
| 2011 Q4 | 4.25 Billion USD | -0.05% |
| 2011 FY | 4.25 Billion USD | -13.72% |
| 2010 Q2 | 5.18 Billion USD | -8.61% |
| 2010 Q4 | 4.93 Billion USD | -3.88% |
| 2010 Q3 | 5.13 Billion USD | -0.96% |
| 2010 FY | 4.93 Billion USD | -16.58% |
| 2010 Q1 | 5.67 Billion USD | -4.13% |
| 2009 FY | 5.91 Billion USD | -12.28% |
| 2009 Q4 | 5.91 Billion USD | -0.15% |
| 2009 Q3 | 5.92 Billion USD | 0.07% |
| 2009 Q2 | 5.92 Billion USD | -5.16% |
| 2009 Q1 | 6.24 Billion USD | -7.43% |
| 2008 Q3 | 6.76 Billion USD | -3.52% |
| 2008 Q1 | 7.31 Billion USD | -7.84% |
| 2008 FY | 6.74 Billion USD | -15.0% |
| 2008 Q4 | 6.74 Billion USD | -0.35% |
| 2008 Q2 | 7.01 Billion USD | -4.06% |
| 2007 Q3 | 7.9 Billion USD | -4.21% |
| 2007 FY | 7.93 Billion USD | -10.82% |
| 2007 Q1 | 8.89 Billion USD | 0.03% |
| 2007 Q2 | 8.25 Billion USD | -7.28% |
| 2007 Q4 | 7.93 Billion USD | 0.38% |
| 2006 Q4 | 8.89 Billion USD | 0.02% |
| 2006 Q1 | 1.83 Billion USD | -1.5% |
| 2006 FY | 8.89 Billion USD | 377.2% |
| 2006 Q2 | 8.89 Billion USD | 384.31% |
| 2006 Q3 | 8.89 Billion USD | 0.01% |
| 2005 FY | 1.86 Billion USD | 63.65% |
| 2005 Q1 | 1.11 Billion USD | -2.11% |
| 2005 Q2 | 1.51 Billion USD | 36.14% |
| 2005 Q3 | 2.43 Billion USD | 60.08% |
| 2005 Q4 | 1.86 Billion USD | -23.29% |
| 2004 Q3 | 1.74 Billion USD | -1.25% |
| 2004 Q2 | 1.76 Billion USD | 188.38% |
| 2004 Q4 | 1.13 Billion USD | -34.54% |
| 2004 Q1 | 611 Million USD | -47.87% |
| 2004 FY | 1.13 Billion USD | -2.82% |
| 2003 Q2 | 974 Million USD | 17.92% |
| 2003 Q3 | 977 Million USD | 0.31% |
| 2003 Q4 | 1.17 Billion USD | 19.96% |
| 2003 FY | 1.17 Billion USD | 38.37% |
| 2003 Q1 | 826 Million USD | -2.48% |
| 2002 Q3 | 840 Million USD | 0.6% |
| 2002 Q4 | 847 Million USD | 0.83% |
| 2002 FY | 847 Million USD | -12.95% |
| 2002 Q1 | 909 Million USD | -6.58% |
| 2002 Q2 | 835 Million USD | -8.14% |
| 2001 FY | 973 Million USD | 69.51% |
| 2001 Q2 | 568 Million USD | 0.0% |
| 2001 Q4 | 973 Million USD | 13.27% |
| 2001 Q3 | 859 Million USD | 51.23% |
| 2001 Q1 | 568 Million USD | -1.05% |
| 2000 FY | 574 Million USD | -15.34% |
| 2000 Q1 | 570 Million USD | -15.93% |
| 2000 Q4 | 574 Million USD | 1.41% |
| 2000 Q2 | 567 Million USD | -0.53% |
| 2000 Q3 | 566 Million USD | -0.18% |
| 1999 Q2 | 1.06 Billion USD | -15.87% |
| 1999 Q1 | 1.26 Billion USD | -7.61% |
| 1999 FY | 678 Million USD | -50.29% |
| 1999 Q3 | 761 Million USD | -28.21% |
| 1999 Q4 | 678 Million USD | -10.91% |
| 1998 Q1 | 554.9 Million USD | 1098.49% |
| 1998 FY | 1.36 Billion USD | 2845.57% |
| 1998 Q3 | 553.9 Million USD | 0.49% |
| 1998 Q4 | 1.36 Billion USD | 146.22% |
| 1998 Q2 | 551.2 Million USD | -0.67% |
| 1997 FY | 46.3 Million USD | -1.91% |
| 1997 Q1 | 47.2 Million USD | 0.0% |
| 1997 Q2 | - USD | -100.0% |
| 1997 Q3 | 49.9 Million USD | 0.0% |
| 1997 Q4 | 46.3 Million USD | -7.21% |
| 1996 Q4 | 47.2 Million USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 FY | 47.2 Million USD | 263.08% |
| 1996 Q1 | - USD | -100.0% |
| 1995 Q1 | 9.2 Million USD | 3.37% |
| 1995 Q2 | 9.1 Million USD | -1.09% |
| 1995 Q3 | 9.1 Million USD | 0.0% |
| 1995 Q4 | 13 Million USD | 42.86% |
| 1995 FY | 13 Million USD | 46.07% |
| 1994 Q1 | 6 Million USD | 0.0% |
| 1994 Q3 | 8.9 Million USD | 0.0% |
| 1994 Q2 | 8.9 Million USD | 48.33% |
| 1994 Q4 | 8.9 Million USD | 0.0% |
| 1994 FY | 8.9 Million USD | 48.33% |
| 1993 FY | 6 Million USD | -1.64% |
| 1993 Q4 | 6 Million USD | 0.0% |
| 1993 Q1 | 6.1 Million USD | 0.0% |
| 1993 Q2 | 6.1 Million USD | 0.0% |
| 1993 Q3 | 6 Million USD | -1.64% |
| 1992 Q1 | 23.2 Million USD | 8.41% |
| 1992 FY | 6.1 Million USD | -71.5% |
| 1992 Q3 | 6.4 Million USD | -72.65% |
| 1992 Q2 | 23.4 Million USD | 0.86% |
| 1992 Q4 | 6.1 Million USD | -4.69% |
| 1991 FY | 21.4 Million USD | 0.0% |
| 1991 Q4 | 21.4 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott Laboratories | 13.59 Billion USD | 34.105% |
| Allurion Technologies Inc. | 2.3 Million USD | -388494.97% |
| Artivion, Inc. | 305.53 Million USD | -2832.927% |
| Avanos Medical, Inc. | 159.4 Million USD | -5521.706% |
| Butterfly Network, Inc. | 22.83 Million USD | -39142.391% |
| Butterfly Network, Inc. | 22.83 Million USD | -39142.391% |
| Bio-Rad Laboratories, Inc. | 1.18 Billion USD | -653.372% |
| CONMED Corporation | 971.48 Million USD | -822.404% |
| Edwards Lifesciences Corporation | 670 Million USD | -1237.463% |
| Paragon 28, Inc. | 109.79 Million USD | -8061.277% |
| Glaukos Corporation | 383.73 Million USD | -2235.187% |
| Globus Medical, Inc. | 417.4 Million USD | -2046.862% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -35966.168% |
| Integer Holdings Corporation | 959.92 Million USD | -833.51% |
| Medtronic plc | 23.87 Billion USD | 62.47% |
| Myomo, Inc. | 115.16 Thousand USD | -7781247.69% |
| Nevro Corp. | 211.47 Million USD | -4137.46% |
| Owlet, Inc. | 22 Thousand USD | -40731718.182% |
| Penumbra, Inc. | 220.9 Million USD | -3956.421% |
| Vicarious Surgical Inc. | 13.78 Million USD | -64905.441% |
| Smith & Nephew plc | 2.17 Billion USD | -312.0% |
| Sonendo, Inc. | 14.03 Million USD | -63747.524% |
| STERIS plc | 3.12 Billion USD | -187.197% |
| Stryker Corporation | 10.9 Billion USD | 17.797% |
| Vapotherm, Inc. | 109.97 Million USD | -8047.993% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | -84.083% |